For sinus diseases, targeted delivery at affected sinonasal sites can be the key to improve efficacy of topical sprays as a nasal therapeutic. Considering that ostiomeatal complex (OMC) is the mucociliary drainage pathway and airflow exchange corridor between the main airway and the frontal, maxillary, and anterior ethmoid sinuses, we have identified sprayer techniques that are more effective in targeting OMC, along with the sinus cavities. Nasal airflow and drug transport have been numerically simulated in five CT-based sinonasal airway reconstructions, drawn from pre-operative chronic rhinosinusitis patients. In each digital model, we applied two different spray orientations at 5-mm insertion: (a) package insert-based direction -an upright spray axis with subject-head inclined slightly forward (22.5 • ), (b) line-of-sight (LoS) -with spray axis directed at OMC and through centroid of visible OMC's projection on the view-plane for best OMC-sighting. LoS protocol registered an average 8-fold higher targeted delivery, with the finding supported by both parametric t-test and non-parametric Wilcoxon signed rank test. Simulated dose in two representative models was validated by in vitro spray experiments in 3D-printed replicas. Finally, observational LoS scores, based on how much of OMC was visible from nostrils, correlated well with the ratio of the projected area of the OMC on the nostril plane to the area of the nostril plane itself. While these CFD-based findings can eventually translate into new personalized spray usage instructions and change the standard-ofcare for nasal treatments, this study also demonstrates how use of relatively simple engineering tools can revolutionize everyday healthcare.
Introduction
Inside our nose, there is a complicated mechanistic assortment (see Figure 1 ) comprising the main nasal passage, the mucociliary hairs and drainage fluid along its internal walls, and the adjoining sinus cavities of various shapes and sizes. 1, 2 Occlusion of these sinus chambers is a common symptom associated with many nasal ailments, such as chronic rhinosinusitis. 3 While surgical treatments essentially focus on enlarging the opening to the sinus chambers, such procedures can be cost-intensive. As a first line of treatment, the physicians often recommend the use of topical sprays, 4, 5 with the rationale that these topical drugs will reduce inflammation at the diseased sites and assist in releasing the occlusion. While such sprays do rank amongst the most commonly used therapeutics for nasal conditions, the efficacy of the drugs can be highly patient-specific and there is no well-defined protocol to ensure that specific dosage would reach the internal target sites inside the nasal passage. Transport of topical drugs inside the nose encounters a number of challenges, namely the tortuosity of the complicated airway geometry, the sweeping effect of the mucociliary drainage, and lack of consistent usage protocol for the medical device used for drug application, primarily owing to the inter-subject variations in the internal anatomic geometry. While tracking the trajectories for topical nasal drug transport in real human subjects is still improbable, with advancement of computational tools, there has been a significant push to obtain numerically simulated predictions of respiratory flow physics and transport therein; see e.g. [6] [7] [8] Of interest are nasal spray simulation studies on in silico models, re-constructed from medical imaging, to measure drug delivery along the nasal passages, 9 in the sinuses, 10 and on the effects of surgical alternations of the anatomy for the nasal airflow [11] [12] [13] as well as for topical transport of drugs. [14] [15] [16] The latter addresses the role of airway channel geometry on airflow-particle interactions. Also, while using medical devices like sprayers, which are inserted at the nostril, the anterior airway geometry gets altered. To simplify the situation a bit, computational results 10 suggest that such initial perturbation do not significantly change or adversely affect the eventual drug deposits at the diseased sites much. There is, however, a distinct lack in articulating a proper guidance system on what could be the "best" way to use the commercially available sprayers, to ensure maximal drug delivery for the patients. First, numerical studies often do not use a realistic spray particle size distribution in the simulations. Focusing on specific particle sizes can be resourceful in studying the detailed nuances of transport characteristics in that size range; however that somewhat limits the applicability of the subsequent findings while predicting the performance of real sprays. Secondly, the inter-subject anatomic variations also render it difficult to figure out a generic spray orientation that can work for all, to ensure maximal delivery of drugs at the target diseased locations inside the nose.
In this study, we have numerically tracked the transport of therapeutic particulates from nasal sprays via inhaled airflow. The computational fluid dynamics (CFD) models of particle transport and the in silico prediction of their deposition sites along the nasal airway walls have been compared with in vitro spray experiments in 3D-printed solid replicates of the same anatomic models. We have proposed a new strategy of nasal spray usage and the recommendation is supported by a significant improvement in target site particle delivery (TSPD), when compared to the prevalent spray usage techniques. The study also opens up the potential of using CFD as a tool in nasal ailment treatment and subject-specific prognosis, and can contribute to the development of non-invasive personalized therapeutics and treatment strategies. Preliminary results pertaining to this work have featured at the American Physical Society (APS) -Division of Fluid Dynamics Annual Meetings 17, 18 and at the International Society for Aerosols in Medicine (ISAM) Congress. 19, 20 2. Methods
Anatomic reconstructions
We have incorporated de-identified computed tomography (CT) data from three presurgery chronic rhinosinusitis (CRS) patients; under approval with exempt status from the Institutional Review Board (IRB) at the University of North Carolina at Chapel Hill. Patient 1 was a 41 years-old Caucasian male (body weight 88 kgs, body mass index 25.3); patient 2 was a 70 years-old Caucasian male (body weight 67.5 kgs, body mass index 24.8); and patient 3 was a 24 years-old Caucasian female (body weight 93.1 kgs, body mass index 32.6). Medical-grade CT scans of the subjects' nasal airways were used to re-construct digital airway models through thresholding of the image radiodensity, at a typical delineation range of -1024 to -300 Hounsfield units for airspace. 10, 21 As part of that process, the DICOM (Digital Imaging and Communications in Medicine) files for each subject were imported to the image processing software Mimics 18.0 (Materialize TM , Plymouth, Michigan). For this study, we subsequently considered each side of the in silico models as a distinct nasal passage model, while studying the spray transport properties on that side: (a) patient 1's right side was the nasal passage model 1 (NPM1) and his left side was nasal passage model 2 (NPM2); (b) patient 2's left side was nasal passage model 3 (NPM3); and (c) patient 3's right side was nasal passage model 4 (NPM4) and her left side was nasal passage model 5 (NPM5).
To prepare the in silico anatomic models for numerical simulation of the inhaled airflow and the sprayed particle transport therein, the airway volume was meshed and segregated into minute volume elements. The meshing was implemented by importing the Mimics-output in STL (stereolithography) file format to ICEM-CFD (ANSYS TM , Canonsburg, Pennsylvania). As per established protocol, 10, 22 each computational grid comprised approximately 4 million unstructured, graded tetrahedral elements; along with four prism layers of 0.1-mm thickness extruded at the airway-tissue boundary with a height ratio of 1.
Inspiratory airflow and sprayed particle transport simulations
Laminar steady-state models work as a reasonable approximation while modeling comfortable resting to moderate breathing; see e.g. 8, [23] [24] [25] [26] Furthermore, with our simulations focusing on a single cycle of inspiration, steady state flow conditions were adopted as a feasible estimate for resting breathing. Based on the principle of mass conservation (continuity), and assuming that the airflow density stays unchaged over time (incompressibility), we have ∇ · u = 0.
(1)
Here u is the velocity field of the inspired air. Conservation of linear momentum under steady state flow conditions would lead to the modified Navier-Stokes equations, which are
Here ρ = 1.204 kg/m 3 represents the density of air, µ = 1.825 × 10 −5 kg/m.s is air's dynamic viscosity, p is the pressure in the airway, and b stands for other body accelerations resulting from gravity, inertia etc. To simulate the airflow, Equations (1) and (2) were numerically solved through a finite volume approach, in the inspiratory direction. The computational scheme employed a segregated solver, with SIMPLEC pressure-velocity coupling and second-order upwind spatial discretization. Solution convergence was obtained by minimizing the residuals (mass continuity ∼ 10 −2 , velocity components ∼ 10 −4 ), and through stabilizing the mass flow rate and the static outlet pressure at the nasopharynx of the digital models. A typical simulation convergence run-time with 5000 iterations clocked approximately 10 hours, for 4-processor based parallel computations run at 4.00 GHz speed. The numerical solution implemented the following set of boundary conditions: (1) zero velocity at the airway-tissue interface i.e. at the tissue surface (no slip at the walls, along with "trap" boundary conditions for particle tracking); (2) zero pressure at nostril planes, which were the pressure-inlet zones in the simulations (with "reflect" boundary conditions to re-direct escaping particles back into the airspace); and (3) a negative outlet pressure (with "escape" boundary conditions for particle tracking) proportionate to the inhalation airflow rate estimated from subject-specific allometric scaling:V = 1.36 M 0.44 for males (while sitting awake) andV = 1.89 M 0.32 for females (while sitting awake). These scaling laws have been derived 27 for a healthy cohort, withV as the minute volume in liters per minute and M as the subject's body mass in kilograms. The relations were deemed applicable for the current subjects based on congruity of breathing patterns between CRS patients without nasal polyps and nonsymptomatic healthy individuals.
After simulating the airflow, sprayed particle transport was tracked through discrete phase particle transport simulations in the ambient airflow, and the corresponding Lagrangian tracking estimated the localized deposition along the airway walls (with trap boundary conditions). Post-processing of the simulated data laid out the spatial deposition trends, which were then tallied against the physical observations. The simulations utilized a Discrete Phase Model (DPM), in which Lagrangian particle tracking obtained the individual trajectories by numerically integrating the particle transport equations: 28
The parameters here include u p , which represents the particle velocity; along with u as the airflow field velocity, ρ and ρ p respectively as the air and particle densities, g as the gravitational acceleration, F B as any other additional body forces per unit particle mass (as for example, Saffman lift force that is exerted by a typical flow-shear field on small particulates transverse to the airflow direction), and F D (u−u p ) quantifies the drag force contribution per unit particle mass. Mean particle time step was evaluated to be of the order 10 −5 s, with the minimum and maximum limits for the adaptive step-size being ∼ 10 −10 s and ∼ 10 −3 s, respectively. Also note that the solution scheme posits the particulate droplets to be large enough so as to ignore any possible Brownian motion effects on their dynamics. TSPD in the OMC and the sinuses were evaluated in terms of the deposited mass fraction percentage (∆ M F ) , which was computed as ∆ M F = 100× W target /W S ; with W target being the net weight of the particulate droplets deposited in the OMC and the sinus cavities, and W S being the weight of one spray shot.
3D printing and physical experiments
To check the reliability of numerically predicted topical deposition vis-à-vis physical experiments, we generated 3D-printed solid models of two subject airways, made from the stereolithograohy material Watershed ® (DSM Somos ® , Elgin, Illinois). Postdigitization, the printing job was sub-contracted to the ProtoLabs (Maple Plain, Minnesota). See Figure 2 2.3.1. Recording deposits through gamma scintigraphy: Topical deposition was tracked through in vitro measurements in 3D-printed solid anatomic replicates. To ensure that the spray axis orientation and nozzle location align with the corresponding simulated spray parameters, we used an aiming slot inserted at the nostril. The spray bottle was fitted into the slot, while administering the nasal spray via hand-pumping. Note that for each sample test, a bottle of commercial nasal spray Nasacort™ was labeled with mildly radioactive Technetium (Tc99m). A compressor setup simulated the weightbased inhalation airflow through the model (assuming open nostrils), at the time of dispensing the spray shots. The corresponding setup is shown on Fig. 2(d) -(e). The topical deposition was proportional to the radioactive signals emitted from the spray solution traces that had deposited inside the solid model and was quantifiable through image-processing of the scintigraphy visuals, collected using a 2D gamma camera. The images were processed in ImageJ 29 by constructing a region of interest (ROI) referenced to fixed Americium sources on the solid model. Figure 3 : Panels (a), (b), and (c) depict the gridline schematic used to extract the deposition fractions from the gamma scintigraphy-based quantification of the sprayed deposits in the solid replicates. The models are segragated into 3 sets of compartments: sagittal columns, sagittal rows, and front columns. Panel (d) shows the perturbation of the base gridline by 1 pixel. Representative Technetium signals are in panel (e). Note: in regards to the axis system, the circle with solid dot implies out-of-plane direction from this page, the circle with cross signifies into-the-plane of this page.
2.3.2.
Model segmentation for comparison with numerical data: To facilitate comparison between the numerical data on particle deposition along the internal walls of a digital model and the physical observation of gamma scintigraphy signals, we segregated two of the test models, NPM1 and NPM2, into virtual segments oriented along three different directions. Figure 3 lays out the Cartesian coordinate directions of the 3D space. X was in the sagittal direction from left to right of the nasal model, Y was directed axially from inferior to superior side of the model, and Z was in the front-toback coronal direction relative to the model. The virtual segments were oriented along the XY, YZ, and ZX planes. Parallel to the XY coronal plane, the models contained 12 segments (named, C12 -C1 ⇒ sagittal columns); there were 9 compartments (C1 -C9 ⇒ front columns) parallel to the YZ sagittal plane, and there were 12 compartments (R1 -R12 ⇒ sagittal rows) parallel to the ZX axial plane. Refer to Figure 3 for the details on the compartmental orientation. For each compartment, the particulate deposition fractions predicted from the computational simulations were compared with the deposition fractions measured based on gamma signals of the deposited particulates in the corresponding compartment in the solid model. The latter was obtained by superimposing the compartmental grid on the radio-images and then extracting the signal from each virtual compartment.
Parameters for the simulated sprayshot
Nasacort™(generic name: Triamcinolone Acetonide), a commonly prescribed and commercially available nasal spray, was selected for this study. Four units of Nasacort™ were tested at Next Breath, LLC (Baltimore, MD, USA) to check for the in vitro spray performance. Corresponding plume geometry was analysed through a SprayVIEW ® NOSP, which is a non-impaction laser sheet-based instrument. Averaged spray half-cone angle was estimated at 27.93 • , and the droplet sizes followed a lognormal distribution. With the droplet diameter as x, the particle size distribution can be framed as a probability density function of the form:
Here, x 50 = 43.81 µm is the count median diameter (alternatively, the geometric mean diameter 30 ) and σ g = 1.994 is the geometric standard deviation. The latter quantifies the span of the particle size data. Note that the mean spray exit velocity from the nozzle was estimated to be 18.5 m/s, based on phase doppler anemometry-based measurements. 31 While simulating the particle trajectories, we assumed typical solidcone type injections and tracked the transport for 1 mg of spray shot while doing the experimental comparisons (since we compared the relative deposition fractions without knowing the exact quantity of particulate mass sprayed in the physical experiments) and 95.0306 mg (which is the experimentally determined spray shot quantity for Nasacort™, as tested by Next Breath, LLC) while comparing the TSPD for the LoS and the CU protocols in each model.
2.5.
Identification of target site and spray positioning parameters 2.5.1. Effect of airflow on particle trajectories: Inertial motion of a particle is linearly proportional to its mass, and hence is exponentially proportional to the particle diameter to a cubic power. Consequently, for bigger particles, their inertial motion persists longer before being taken over by the ambient airflow. Figure 4 (a) tracks the trajectory of a representative 5µ particle. The red circle marks the location where the inertial motion of the particle got overwhelmed by the ambient flow, beyond which the particle trajectory is
Sprayed particulates ≥ 100μ Sprayred particulates of sizes 5 -525μ
Representative 5μ particle trajectory Representative 25μ particle trajectory Figure 4 : Comparison of trajectories of a representative 5µ particle and a representative 25µ particle in a sample sinonasal airspace. In panel (a), the smaller particle has a weaker inertial motion and the ambient airflow streamline takes over its motion much earlier than that in case of a heavier particle like the one in panel (b), where the inertial motion of the 25µ particle persists longer. The small red circle in (a) depicts the point where the inertial motion gets overwhelmed by the fluid streamline. Evidently, owing to smaller inertia, the particles with smaller diameters get predominated by the airflow streamlines earlier than the bigger particles. This results in a better penetration and spread of sprayed particles in the nasal airspace, as shown in panel (c). On the contrary, spray shots with exclusive share of bigger particles (e.g. > 100µ here) tend to follow their initial inertial trajectories, without much effect of the airflow streamlines on their paths, and deposit along the anterior walls of the nasal airspace, as depicted in panel (d). Note: These images were created using FieldView, as provided by Intelligent Light through its University Partners Program.
same as the airflow streamline on which it was embedded at the red circle location. Note the contrasting 25µ particle trajectory in Figure 4(b) , where the inertial motion persists longer. The phenomenon has a significant impact on the eventual drug deposition along the walls. The bigger particles (>100µ) show a greater propensity to hit the anterior walls directly because of their stronger inertial motion, while spray shots with smaller particle sizes do a better job at penetrating further into the airspace; see e.g. Figure 4 (c)-(d). So, to ensure that the bigger particles also reach the target sites, we argue that it would be conducive to actually utilize their inertial motion and have most of those particles directed towards the target when they exit the spray nozzle. This can be achieved by orienting the spray axis towards the intended anatomic target.
Current use instructions:
There are ambiguities on the current protocol to use nasal spray devices. Different commercial sprayers often offer somewhat contrasting recommendations. However, there is a common agreement (see Figure 5 (a)) that the patient should incline their head forward while applying the spray. There is also a clinical recommendation of not having the spray directed straight towards the septum. We have adopted these two features in our standardization of "Current Use" (CU) protocol for topical sprays. The digital models were inclined forward by an angle of 22.5 • , and the vertically upright spray axis was closer to the lateral nasal wall, at one-third of the distance between the lateral side and septal wall. Also, the spray bottle penetrates into the airspace by a distance of 5 mm, inspired by the package recommendations of commercial sprayers for a "shallow" insertion into the nose. Figure 5 (b) lays out the schematics of the current use protocol for this study.
2.5.3.
Proposing alternate use criteria -Line of sight: All the sinuses drain into the ostiomeatal complex (OMC), it being the main mucociliary drainage pathway and airflow exchange corridor between the airway and the adjoining sinus cavities. To ensure that as many drug particulates reach the sinus chambers and their vicinity as would be possible, we hypothesize that the spray axis should be directed straight towards the OMC. This is supported by our observation of the effect of airflow physics on particle trajectories (see discussion in Section 2.5.1). If the spray axis hits the OMC directly, the chances that the larger particles will deposit there is higher. In this study, we refer to this usage protocol as "Line of Sight" (LoS) use. Like the CU protocol, the LoS usage also had the sprayer inserted at a depth of 5-mm into the nasal airspace. Representative LoS orientation is shown in Figure 6 .
Results

Comparison between CU and LoS spray usage protocols
LoS was found to be consistently better than the CU spray placement protocol, while targeting the OMC and the sinus cavities for drug delivery. Table 1 lists the deposition fraction percentages for each spray release condition in the 5 airway models (NPM1 The numbers are the deposition mass fraction percentages in the Sinus + OMC region, for each spray shot (95.0306 mg) of Nasacort.
The '-' entries imply that the corresponding peripheral spray release locations were actually outside the digital internal nasal airspace. -NPM5). For a graphical interpretation, we have plotted the same information on Figure 7 . Overall, the deposition fraction for the LoS was on an average 8.0-fold higher than the CU deposition fraction, with the corresponding subject-specific improvement range being 1.8 -15.8 folds for the five test models. The improvement does decay when the peripheral spray directions are compared, to assess the robustness of the LoS protocol over CU. Note that the peripheral directions for CU initiate 1 mm away on the nostril plane and are parallel to the true CU direction, and for LoS, its peripheral directions are obtained by connecting the base of the true LoS direction on the nostril plane and the points 1 mm away on the projection of the OMC on the view-plane for best-possible OMC sighting from outside the nostril. Considering the varying peripheral directions around the true LoS and CU, the LoS set registered a mean 2.9-fold increase in TSPD, with the corresponding subject-specific improvement range being 1.6 -4.5 folds.
3.1.1. Statistical tests -on improvements achieved by the revised strategy for spray use:
LOS was compared to CU using a paired study design with the data from the five test models (NPM1 -NPM5). Table 2 lays out the computed numbers. For each of the five nostril models the outcomes were percentage of deposition in OMC plus sinuses for the CU direction as well as the LoS direction. The percentage of deposition for the CU and LoS directions from the same nostril were treated as paired observations for a paired t-test to check the hypothesis that the percentage of deposition is the same for CU and LoS. Because of the low number of observations, a paired Wilcoxon signed rank test was also used as a robustness check. In order to study how spatial variation might affect the difference between CU and LoS, three different ways of calculating the percentage of deposition were implemented. The first was using the average deposition from the true LoS and CU directions. The second was by averaging the simulations from the true CU and LoS directions, along with the TSPD for 5 -8 spray release parameters obtained by perturbing the respective true directions. The third was by averaging just the simulations from the release points perturbed from the true LoS directions. This allowed us to see if any improvement from using LoS instead of CU was robust to slight spatial variations. The results show that calculating percentage of deposition using just the true direction LoS results in an average increase deposition of 5.4 percentage points relative to current use (6.39-%vs.-0.98%). This difference is significant at the 0.05 level with a p-value from the paired t-test of 0.04. The paired Wilcoxon signed-rank test has a p-value of 0.06, which is the lowest possible p-value for the Wilcoxon signed-rank test given only five pairs of data. When calculating the percentage of deposition using true direction as well as the peripheral perturbation spray release points, LoS has an increased deposition of 1.62 percentage points relative to CU (2.49%-vs.-0.87%). The pvalue for this difference is 0.02 using the paired t-test and 0.06 using the Wilcoxon signed rank test. When calculating the percentage of deposition using just the spray release points obtained by perturbing from the true direction, LoS has an increased deposition of 1.05 percentage points relative to current use (1.90%-vs.-0.86%). The p-value for this difference is 0.02 using the paired t-test and 0.06 using the Wilcoxon signed rank test. This shows strong evidence that LoS leads to higher percentage of deposition in the OMC and sinuses compared to CU. The estimated difference is largest when using just the true directions, but the difference is still statistically significant even while using the release points obtained by perturbing the true directions by 1 mm. The p-value from the paired t-test is actually lower when the TSPD from just the perturbed points are considered, owing to the reduced variance for the estimated difference. For all three ways of estimating the percentage of deposition, the paired Wilcoxon signed-rank test has a p-value of 0.06. This indicates that the LoS has higher deposition for all five nostril models because 0.06 is the lowest possible p-value when having only five pairs of data.
Gamma scintigraphy recordings
Intra-nasal topical delivery was tracked through in vitro examination of the mildly radioactive spray deposits in the 3D-printed solid models. Signals emitted from the settled solution traces along the airway walls were subjected to image processing analysis. The spray signals were assigned to compartments by superimposing the previously described grid (see Section 2.3.2) on the radio-image. In order to align the grid on the image in a manner consistent with the virtual model, three inset discs were incorporated as reference points on the outer surface of the virtual and 3D-printed models. Technetium spiked solution was applied to these reference points on the 3Dmodel and a radio-image was recorded. Image processing was performed to align the emitted visual signals with similar reference regions within the superimposed grid. This was done via manual visualization to achieve a best fit of signal intensity within reference regions. The grid compartment planes positioned using this visual best-fit manner were designated as "reference planes". Given the nature of the radioactive signals and the resolution of the radio-image, some signal intensity resided outside of reference regions even while using best-fit practices. A reasonable fit could be obtained by shifting the image one pixel in either direction. In order to account for this variation, alternative plane positions (see Figure 3 (d)) were created by shifting the reference planes one pixel in the positive and negative axes for each set of Cartesian planes, with one pixel corresponding to a distance of 2.38 mm in the virtual and 3D models. These three sets of compartment planes were positioned in the virtual model software using the measured distances from the reference regions. The corresponding Cartesian coordinates of these planes were used to assign particle deposition locations from the computational simulations to grid compartments for comparison with the in vitro model. Figure 8 compares the numerical predictions with corresponding physical spray experiments, in NPM1 and NPM2. While the compartmental deposits present a similar trend in each of sagittal columns, sagittal rows, and front columns; we conducted some statistical tests to verify the homogeneity between the two sets of data, as a means to establishing the reliability of the computational findings. Table 3 gives the Pearson and Kendall's correlation between the numerical and experimental models for the average deposition fraction for NPM1 and NPM2 for the LoS protocol. The confidence intervals are based on 1000 bootstrap samples instead of asymptotic approximations because of the relatively small sample size. Based on the output we can see that the Pearson correlation is consistently very high while the Kendall's correlation is not as high. While the Kendall's correlation is frequently thought to be more robust to outliers, particularly for small sample sizes like this data set; in this instance the Pearson correlation is likely more illustrative. This is because the Pearson correlation is able to show that for the most part the magnitudes of the estimates are the same between the numerical and experimental models. In general, there is a strong linear relationship between the percent of deposition prediction from the numerical model and the corresponding physical measurements in the experimental model. The lower Kendall's correlation (overall mean measure 0.78) is largely due to regions where both the numerical and experimental models had very low average deposition but the exact rank of these regions changed quite a bit between the two. Note that this does not necessarily indicate a poor performing numerical model. However, the very high Pearson correlation (overall mean measure 0.91) does indicate that the numeric model performs well for the considered test models.
Comparison of the simulated predictions with physical experiments
Discussion
CFD-recommended revised nasal spray usage defined by the LoS protocol was found to significantly increase topical drug delivery at targeted sinonasal sites, in comparison to current use conditions. The work is expected to develop instructions and specifications for improved use of topical sprays. This information has the potential to radically improve the treatment paradigm for sinonasal ailments, through ascertaining LoS in individual subjects via endoscopy tests conducted in the clinic itself, and to help guide treatment decision-making and patient instruction in spray usage.
LoS scoring and the adaptibility of the findings in clinical practice
The LoS scores (see Table 4 ) were first determined observationally, based on the visibility of the OMC site from outside the nostril of the in silico sinonasal reconstructions. The range of scores ∈ [ 1, 4 ] , with 4 being used when the LoS was most easy to ascertain. Subjectively anecdotal as that scoring procedure might have been, it is similar to what a practicing physician will do during a regular clinic visit to determine if a particular patient has a "line of sight" in her/his nasal anatomy. So, to establish the relevance of the findings from this manuscript towards revisions of the therapeutic protocol for sinonasal care, it was important to compare the observational LoS scores with more objective determination techniques. Findings pertaining to the latter are also in Table 4 , along with how they compare with the observational scores. We calculated the surface area of the nostril plane and the projected area of the OMC on the plane of the nostril. Following this, we calculated the ratio of the projected area to the nostril area, as a percentage. Scores of 4 were assigned if the ratio exceeded 6%, 3 if the ratio exceeded 4%, 2 if the ratio was more than 1.5%, and 1 if the ratio was greater than 0%. The two techniques of scoring yielded very similar results, with the highest and lowest scores respectively going to the same anatomic models. Pearson's rank correlation for the two sets of scores was 0.85. While a broader study, involving clinical trials, will be necessary to revise therapeutic protocol for sinus drug delivery, the present results hence show the promise for easy adaptability into clinical practice settings.
Caveats on the comparability of the experimental data with the numerical findings
The computational simulations assumed a laminar framework to mimic steady breathing. However, it may be argued that even at steady breathing rates, the airflow often depict transitional features like vortices, that emerge from the roll-up of shearing fluid layers during the flow-structure interactions 32, 33 at the anatomic bends. Some of these nuances are, in fact, hard to model without proper turbulence simulations. 34, 35 However, true as that may be, the effect of these flow artifacts on drug delivery has been found to be insignificant through comparing laminar and turbulence simulation results, e.g. see. 10 On the other hand, if we ponder on the comparability of the numerical data with the physical experiments, the in vitro techniques often present a series of challenges. For example, after being deposited, the spray solution can move around along the inner walls of the solid replicate. Such drip-off dynamics can often lead to a flawed estimate of regional deposition in the spray experiments. Also, in the gamma scintigraphy method of recording deposits, the radiation signal undergoes some level of scattering and hence when we were trying to extract signals from each of the compartments pertaining to the saggital columns, sagittal rows, and front columns; there was always the possibility of the signal from one compartment contaminating the SA ⇒ surface area signals at the neighboring compartments. To minimize this effect while carrying out the comparisons, we left out the front anterior nose (the soft plastic anterior part in the solid models), which had a bright radiation signal owing to the anterior deposits, from both the experimental and numerical data.
Future implications and caveats
We should not ignore the caveat that this was a computational study with validation from inanimate solid replicates. Also, not every patient will have a clear access to the OMC, and hence will be without an LoS. For instance, in the current study, of the six airway sides in the three study subjects, patient 2's right side anatomy did not exhibit an LoS. This study is however, to the best of our knowledge, the first-of-its-kind to propose an alternative easy-to-implement strategy that can significantly improve the intra-nasal delivery of topical drugs at the diseased sites. The recommendations for using the line of sight is user-friendly and has the potential to be smoothly incorporated into the nasal standard-of-care. For probable revisions to the clinical regimen, we will need a broader study with more subjects, along with a component for clinical trials to track patient response. On a larger perspective, this study postulates how relatively simple engineering analysis tools can revolutionize the prognosis and treatment of common ailments like blocked nose.
